Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results

Go back to Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results
POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 15.72 +0.35 (2.28%)
Previous Close $15.37    52 Week High $11.63 
Open $15.72    52 Week Low $9.19 
Day High $16.03    P/E N/A 
Day Low $15.69    EPS $0.00 
Volume 84,817       

POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 15.72 +0.35 (2.28%)
Previous Close $15.37    52 Week High $11.63 
Open $15.72    52 Week Low $9.19 
Day High $16.03    P/E N/A 
Day Low $15.69    EPS $0.00 
Volume 84,817       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.69 +0.08 (3.07%)
Previous Close $2.61    52 Week High $1.11 
Open $2.61    52 Week Low $0.41 
Day High $2.73    P/E N/A 
Day Low $2.58    EPS $-0.29 
Volume 870,832       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.69 +0.08 (3.07%)
Previous Close $2.61    52 Week High $1.11 
Open $2.61    52 Week Low $0.41 
Day High $2.73    P/E N/A 
Day Low $2.58    EPS $-0.29 
Volume 870,832